QHSLab, Inc. (USAQ)
| Market Cap | 4.51M +110.4% |
| Revenue (ttm) | 3.02M +24.6% |
| Net Income | 524.11K |
| EPS | 0.02 |
| Shares Out | 15.03M |
| PE Ratio | 14.05 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 0.3000 |
| Previous Close | 0.3500 |
| Day's Range | 0.3000 - 0.3000 |
| 52-Week Range | 0.0800 - 1.1360 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
About QHSLab
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic mon... [Read more]
Financial Performance
Financial StatementsNews
QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
Integrated Service Program (ISP) Revenue More Than Doubles Year-over-Year as Gross Margins Expand and Financing Costs Decline
QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment
Unaudited Q1 2026 ISP revenue of $370,000, up from $163,000 in Q1 2025, representing 127% year-over-year growth Growth supported by expanding provider adoption, the launch of the Q-Connect AOM and GLP...
QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement
Integrated Service Program Growth Drives Revenue Expansion and Margin Improvement Delivering Improved Profitability and Debt Reduction in Fiscal 2025 Operational Momentum and Balance Sheet Restructuri...
QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt Reduction
Revenue increased 25% year over year, gross margins expanded to approximately 67%, and convertible debt was substantially eliminated Improved profitability and early Q-Cog reimbursement activity posit...
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
Governance evolution follows elimination of major convertible debt, recent funding, and improved capital structure Company advances governance framework aligned with shareholder interests and future l...
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
Unaudited update reflects revenue growth, positive operating income, removal of convertible debt, and improved cash flow profile entering 2026.
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
With legacy overhang removed and new capital secured, management shifts focus from balance-sheet repair to disciplined growth execution.
QHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and Dementia
Initial pilot of 168 patients aged 65 and older identifies 54% with high-risk cognitive scores; digital platform expands company's value-based care capabilities. West Palm Beach, FL, Dec. 03, 2025 (G...
QHSLab (OTCQB:USAQ) Completes Repurchase of Legacy Debt, Enhancing Capital Structure, Strengthening Balance Sheet and Reducing Future Dilution
Repurchase of the Catheter Convertible Notes removes conversion overhang and supports QHSLab's financial discipline and growth outlook. Company Reports Robust Q3 2025 Year-Over-Year Revenue Growth, Ex...
QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health
Back-to-School Season Just Got Smarter The Pediatric Health Assessment empowers parents and providers to uncover hidden health or behavioral issues that may affect academic and social success. QHSLab'...
QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services
Innovative initiative combines QHSLab's digital platform with on-site behavioral health services to advance timely, effective care. MIAMI, FL, July 08, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Compa...
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE ...
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth
WEST PALM BEACH, FL, May 16, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening...
QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025
Revenue increased 32% year-over-year to $645,419, driven by growth in ISP and Allergy Diagnostics Gross margin expanded to 66.6%, reflecting improved product mix and operational efficiencies WEST PALM...
QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program
WEST PALM BEACH, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screenin...
QHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial Results
Four consecutive quarters of year-over-year revenue growth underscore continued business momentum. Revenue surges 98% in Q4 2024 compared to Q4 2023, marking a milestone year for QHSLab.
QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth
Expanding market reach to drive organic revenue growth without equity dilution Collaborating with AI-driven health assessments and customized pharmacy solutions to enhance patient care. Integrating Di...
QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology
NSF Recognition: A Testament to Innovation Driving Strategic Growth and Shareholder Value WEST PALM BEACH, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), a leading pr...
QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024
Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), an emerging leader in digital hea...
QHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy Diagnostics
Revenue Soars 62% Year-Over-Year in Q3 2024, with Gross Margin Expanding to 67.1% Integrated Service Program (ISP) Revenue Up 143% Year-to-Date, Marking Continued Demand for Digital Health Solutions N...
QHSLab, Inc. Welcomes Dr. Juan D. Oms, MD, FAPA, as Medical Advisor for Psychiatry and Behavioral Health
WEST PALM BEACH, FL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proacti...
QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation
WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proact...
QHSLab Inc. Reports Strong Second Quarter and Six-Month 2024 Results
Significant Improvement in Profitability and Cash Flow Management WEST PALM BEACH, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), a leader in digital healthcare and p...
QHSLab, Inc. Announces Strong First Quarter 2024 Results with Significant Reduction in Operating Expenses and Positive Net Operating Income
Integrated Service Program (ISP) Revenues Surge 268% in Q1 2024 Over Q1 2023 WEST PALM BEACH, FL, May 13, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital healt...
QHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs
WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactiv...